Project
- Development of technology for localization of bone graft substitute for High Tibial Osteotomy based on multi-pass extrusion technology.

Project Summary
- Development of high functional Wedge Bone for High Tibial Osteotomy combined with multi-pass extrusion technology.
- Verification of biological safety and effectiveness based on self-assessment of wedge bone and pre-clinical evaluation by accredited certification authority.
- To obtain approval from MFDS for commercialization of Wedge Bone

Business Model
1) Purpose
- As the aging society is accelerating, High Tibial Osteotomy is significantly increasing to slow down total knee replacement surgery which are the main operation of degenerative knee disease.
- The wedge bone currently available in the market is high price allograft or synthetic bone substitute imported from several developed countries.
- Our plan is to secure competitiveness in terms of technology as well as price through new types of wedge bone with application of multi-pass extrusion technology.

2) Core Competitiveness
- High functional Wedge Bone made from bioceramic which is infection and immune rejection free.
- In-house bioceramic production technology ensures smooth raw material supply and price competitiveness
- Human bone mimicking wedge bone with porous structure which provides high-performance in terms of osteoconductive, new bone formation and bio-compatibility.

3) Marketing Strategy
- Successful launching on the domestic market as well as further expansion to overseas market with demonstration of product safety and quality through substantial clinical assessment in leading domestic hospitals.

Main Achievements
- Successful development of high-quality wedge bone for High Tibial Osteotomy.
- Demonstration of product safety through pre-clinical evaluation from KTR.
- Approval from MFDS for successful launching in domestic market.
Date of Establishment2010-11-25
Accelerator(주)벤처스퀘어
StageBiomedical
Date of TIPS Selection2016-04-01